SOURCE: Cutting Edge Information

Cutting Edge Information

March 06, 2017 08:54 ET

Cutting Edge Information Partners with SMi Group for 9th Annual Adaptive Designs in Clinical Trials Conference in London

SMi confirms Pfizer Director of Biostatistics will deliver key presentation exploring adaptive dose-finding designs in oncology early phase trials at the 9th Adaptive Designs in Clinical Trials conference in London in April of this year

RESEARCH TRIANGLE PARK, NC--(Marketwired - March 06, 2017) - Cutting Edge Information is proud to be partnering with SMi Group, a global event-production company that specializes in creating and delivering events with the world's most forward thinking opinion leaders and visionaries. SMi has confirmed that Bo Huang, Director of Biostatistics at Pfizer has joined the expert speaker line-up for the 9th Adaptive Designs in Clinical Trials event on the 3rd & 4th of April 2017 in London.

Bo is an avid advocate of adaptive innovative designs and designed the first Bayesian model-based clinical trial at Pfizer Oncology. Following his successful presentation last year, Bo returns this year to present a keynote on Adaptive Dose Finding Designs in Oncology Early Phase Trials. Through this exclusive presentation, Bo will discuss the time-to-event reassessment method with adaptive weight function incorporating cyclical data. He will also highlight practical implications of adaptive design on Pfizer oncology drug development with two case studies.

In a quickfire interview with SMi Group, Bo commented on the future of adaptive clinical trials.

"I envision more applications of adaptive designs in clinical trials, especially in the pharmaceutical industry. As we enter the era of precision medicine, more statistically efficient designs are appealing to clinical practitioners as a means to lower the ever-increasing cost and shorten the time to reach the market and patients," he said.

The full interview can be read at www.adaptivedesigns.co.uk.

Bo joins a speaker line-up of industry-leading innovators from AstraZeneca, Pfizer, Sanofi, Boehringer-Ingelheim, Grünenthal, Amgen, Novartis, Blueberry Therapeutics, and more.

Now nearly running for a decade, Adaptive Designs in Clinical Trials will feature key presentations that will discuss and deliberate key topics such as new approaches in adaptive designs, clinical strategies, optimising drug development in key therapy areas and industry-led approaches to clinical trial success. A detailed agenda is available to view on www.adaptivedesigns.co.uk/CEIpr.

The event will also feature a post-conference workshop on writing clinical trial simulators hosted by Berry Consultants.

For more details about the conference and registration information, visit the event website.

ADAPTIVE DESIGNS IN CLINICAL TRIALS
3rd & 4th APRIL, 2017
Copthorne Tara Hotel, Kensington, London, UK
www.adaptivedesigns.co.uk

Contact Information for SMi Group:

For sponsorship and exhibition queries please contact Alia Malick at amalick@smi-online.co.uk. For delegate queries please contact Fateja Begum at fbegum@smi-online.co.uk. For media queries please contact Honey de Gracia at hdegracia@smi-online.co.uk.

About SMi Group:
Established since 1993, SMi Group is a global event-production company that specializes in business-to-business conferences, workshops, masterclasses and online communities. SMi creates and delivers events in the defence, security, energy, utilities, finance and pharmaceutical industries. SMi takes pride in having access to the world's most forward thinking opinion leaders and visionaries, allowing them to bring communities together to learn, engage, share and network. More information about SMi can be found at http://www.smi-online.co.uk.

Contact Information